MedMira Inc. is a biotechnology company. The Company is engaged in the development and commercialization of rapid diagnostics and technology platforms. The Company, through its subsidiaries, is engaged in the research, development and manufacturing of rapid diagnostics and technologies. The Company operates in North America, Latin America/Caribbean, Europe, Asia Pacific and Other. It invests in research. The Company�s testing solutions provide hospitals, labs, clinics and individuals with rapid diagnosis for diseases, such as human immunodeficiency virus (HIV) and hepatitis C. The Company�s tests are sold under the Reveal, Multiplo and Miriad brands. Its products consist of HIV, H. Pylori and Syphilis.